Basic Information
| ID | DRAMP21631 |
|---|
| Sequence | RLVRILVSKRPVAIKPYFRL |
|---|
| Length | 20 |
|---|
| Name | SLAY-P1 |
|---|
| Source | Synthetic construct after SLAY screening and prediction |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram- |
|---|
| Pathogen | [Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 2 μM), Acinetobacter baumannii 5075 (MBC ≤ 2 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 2 μM). |
|---|
| Hemolytic Activity | [Ref.29307492] The peptide showed 4.0% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis. |
|---|
| Cytotoxicity | No cytotoxicity information found |
|---|
| N-terminal Modification | Free |
|---|
| C-terminal Modification | Free |
|---|
| Linear/Cyclic/Branched | Linear |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 29307492 |
|---|
